JP Stock MarketDetailed Quotes

4530 Hisamitsu Pharmaceutical

Watchlist
  • 4144.0
  • -16.0-0.38%
20min DelayTrading May 16 10:30 JST
352.92BMarket Cap14.02P/E (Static)

About Hisamitsu Pharmaceutical Company

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Company Profile

Symbol4530
Company NameHisamitsu Pharmaceutical
Founded1944-05-22
MarketTSE Prime
Employees2759
Fiscal Year Ends02-28
Address408 Tashiro Daikan-machi Tosu
Zip Code841-0017
Phone0942-83-2101

Company Executives

  • Name
  • Position
  • Salary
  • Kazuhide Nakatomi
  • Director, President and Chief Executive Officer
  • --
  • Shinichi Murayama
  • Director and Executive Officer
  • --
  • Nobuo Tsutsumi
  • Director and Executive Officer
  • --
  • Kyu Saito
  • Director, Managing Director and Executive Officer
  • --
  • Kosuke Sugiyama
  • Director, Senior Managing Director and Executive Officer
  • --
  • Koji Takiyama
  • Director and Executive Officer
  • --
  • Tamako Watanabe
  • Independent Director
  • --
  • Yuichiro Anzai
  • Independent Director
  • --
  • Tetsugo Matsuo
  • Independent Director
  • --

Market Insights

Tariff Storm Hits: Hedge with ETFs? Tariff Storm Hits: Hedge with ETFs?

The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios. The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios.

Unlock Now

Discussing

中美大降關稅!如何抓住市場交易機會?
中美關稅超預期降溫,市場迎來久違狂歡。5月12日下午,中方公佈中美日內瓦經貿會談聯合聲明,美方取消共計91%的加徵關稅,中方相應取消91%的反制關稅,美方暫停實施24%的「對等關稅」,中方相應暫停實施24%的反制關稅。聲明公佈後,港美股當日應聲暴漲,修復至關稅前水平。13日,特朗 Show More